Rein Therapeutics ("Rein") , formerly known as Aileron Therapeutics, Inc. ("Aileron") , a biopharmaceutical company advancing a ...

Keep an eye on the first patient dosed in phase 1 and 2 trials of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD),with ...

CES® 2025, the most powerful tech event in the world, welcomed over 141,000 attendees from around the globe. With more than ...

Novartis faces short-term challenges with patent expirations but shows long-term growth potential. Click here to read why I ...

How does geography fuel North Carolina expansion? Plus, the H-1B visa debate heats up, net neutrality is dealt a blow, and ...

Leavitt Equity Partners ("LEP"), a value-add, healthcare-focused private equity firm, today announced four promotions, ...

Argonne National Laboratory is managing two microelectronics studies that will support multidisciplinary codesign of hardware and software and enable processing of vast quantities of data at ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Pamela ...